Literature DB >> 6317558

Superoxide radical production by human leukocytes exposed to immune complexes: inhibitory action of gold compounds.

F R Roisman, D T Walz, A E Finkelstein.   

Abstract

Superoxide radicals produced by phagocytic cells are considered to be important mediators in the rheumatoid inflammation. The effect of the gold compounds auranofin (AF) and gold sodium thiomalate (GST) on superoxide production by human leukocytes was investigated in two models of immunologic injury: immune-complex phagocytosis and frustrated phagocytosis. In both systems, AF (0.5-1.0 micrograms Au/ml) showed a potent inhibitory activity on superoxide generation, quantitated by ferricytochrome c and NBT reduction. GST showed only modest inhibition at higher concentrations (100 microM). The thiol protecting agent dithiothreitol, 1 mM, completely blocks the inhibitory effect of AF. The inhibition of the oxy radical generation by AF may play an important role in the control of rheumatoid inflammation; it is suggested that this action might be mediated through sulfhydryl-AF interaction at the cellular membrane level.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317558     DOI: 10.1007/bf00916300

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  19 in total

1.  Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial.

Authors: 
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

2.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

3.  Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.

Authors:  A E Finkelstein; F R Roisman; V Batista; F G de Nudelman; E H de Titto; M Mizraji; D T Walz
Journal:  J Rheumatol       Date:  1980 Mar-Apr       Impact factor: 4.666

4.  Effect of auranofin, a new antiarthritic agent, on immune complex-induced release of lysosomal enzymes from human leukocytes.

Authors:  A E Finkelstein; F R Roisman; D T Walz
Journal:  Inflammation       Date:  1977-06       Impact factor: 4.092

5.  Gold-induced changes in the morphology and functional capabilities of human monocytes.

Authors:  K Ugai; M Ziff; P E Lipsky
Journal:  Arthritis Rheum       Date:  1979-12

6.  Phagocyte-produced free radicals: roles in cytotoxicity and inflammation.

Authors:  J M McCord; K Wong
Journal:  Ciba Found Symp       Date:  1978 Jun 6-8

7.  Auranofin. New oral gold compound for treatment of rheumatoid arthritis.

Authors:  A E Finkelstein; D T Walz; V Batista; M Mizraji; F Roisman; A Misher
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

8.  Assessment of immune response during chrysotherapy. Comparison of gold sodium thiomalate vs. auranofin.

Authors:  A Lorber; W H Jackson; T M Simon
Journal:  Scand J Rheumatol       Date:  1981       Impact factor: 3.641

9.  Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.

Authors:  J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

10.  Studies of the effect of auranofin, a new antiarthritic agent, on platelet aggregation.

Authors:  I Nathan; A E Finkelstein; D T Walz; A Dvilansky
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

View more
  5 in total

1.  Antiarthritic synergism of combined oral and parenteral chrysotherapy. II. Increased inhibition of activated leukocyte oxygen burst by combined gold action.

Authors:  A E Finkelstein; M Ladizesky; R Borinsky; E Kohn; I Ginsburg
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

2.  Auranofin in the treatment of steroid dependent asthma: a double blind study.

Authors:  G Nierop; W P Gijzel; E H Bel; A H Zwinderman; J H Dijkman
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 3.  Acute septic arthritis.

Authors:  Mark E Shirtliff; Jon T Mader
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

4.  Gold(I/III)-Phosphine Complexes as Potent Antiproliferative Agents.

Authors:  Jong Hyun Kim; Evan Reeder; Sean Parkin; Samuel G Awuah
Journal:  Sci Rep       Date:  2019-08-26       Impact factor: 4.379

Review 5.  Pathogenic organisms in hip joint infections.

Authors:  Udo Geipel
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.